Modeling the pathway of breast cancer in the Middle East
Author:
Amer Asmaa12, Nagah Ahmed13, Osman Mojeeb AL-Rahman El-Nor1, Majid Abdul1
Affiliation:
1. School of Mathematics and Statistics , Central China Normal University , Wuhan , , P. R. China 2. Faculty of Science, Mathematics Department , Menoufia University , Egypt 3. Faculty of Science, Mathematics Department , Zagazig University , Egypt
Abstract
Abstract
This paper proposed an approach for the identification of mutation mechanisms of breast cancer in women in four member countries of the Middle East Cancer Consortium i.e. Egypt, Jordan, Cyprus and Israel (Arabs and Jews). We set up multistage models including both gene mutation and the clonal expansion of intermediate cells. We fit the data-set related to the incidence of female breast cancer in the four member countries. Our simulation results show that the maximum number of driver mutations of breast epithelium stem cells of Egyptian women is 13, whereas there are 14 driver mutations in the genome of stem cells of female patients in Jordan, Cyprus and Israel (Arabs and Jews). In addition, the 3, 10, 5, 5 and 4 stage models are the optimal ones for the tumorigenesis of females in Egypt, Jordan, Cyprus, Israel (Arabs) and Israel (Jews), respectively. The genomic instability is caused by first three driver mutations.
Publisher
Walter de Gruyter GmbH
Subject
Applied Mathematics,Engineering (miscellaneous),Modeling and Simulation,General Computer Science
Reference45 articles.
1. Rennert G.: Breast cancer, In Cancer Incidence in the Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. Volume (Chapter 8). Edited by L. S. Friedman, B. K. Edwards, L. A. G. Ries, J. L. Young. National Cancer Institute. NIH Pub No. 06-5873. Bethesda, MD;:73–81, (2006). 2. N. A. Lakkis, S. M. Adib, M. H. Osman, U. M. Musharafieh, and G. N. Hamadeh, Breast cancer in Lebanon: Incidence and comparison to regional and western countries, Cancer Epidemiology, vol. 34, no. 3, 221–225, (2010). 3. T. V. Clendenen, W. Ge, K. L. Koenig, Y. Afanasyeva, C. Agnoli, L. A. Brinton, F. Darvishian, J. F. Dorgan, A. H. Eliassen, R. T. Falk, et al., Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the gail model, Breast Cancer Research, vol. 21, no. 1, pp. 42, (2019). 4. A. M. Falstie-Jensen, A. Kjrsgaard, E. L. Lorenzen, J. D. Jensen, K. V. Reinertsen, O. M. Dekkers, M. Ewertz, and D. P. Cronin-Fenton, Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality-a danish population-based study, Breast Cancer Research, vol. 21, no. 1, pp. 44, (2019). 5. C. M. Vachon, C. G. Scott, R. M. Tamimi, D. J. Thompson, P. A. Fasching, J. Stone, M. C. Southey, S. Winham, S. Lindstrm, J. Lilyquist, et al., Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk, Breast Cancer Research, vol. 21, no. 1, pp. 68, (2019).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|